NCT05123807View on ClinicalTrials.gov

Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 7, 2022

Primary Completion Date

February 2, 2027

Study Completion Date

February 2, 2027

Conditions
Ovarian Cancer
Interventions
OTHER

Cytoreductive surgery

(an operation to remove as much tumor tissue as possible) with hyperthermic intraperitoneal chemotherapy

Trial Locations (1)

77030

RECRUITING

MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER